Cargando…

Galectin-3 and cyclin D1 expression in non-small cell lung cancer

INTRODUCTION: Lung cancer is a major cause of mortality and morbidity worldwide. Galectin-3 is multifunctional protein, which is involved in regulation of cell growth, cell adhesion, cell proliferation, angiogenesis and apoptosis. Cyclin D1 together with other cyclin plays an important role in cell...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kosacka, Monika, Piesiak, Paweł, Kowal, Aneta, Gołecki, Marcin, Jankowska, Renata
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3214148/ https://www.ncbi.nlm.nih.gov/pubmed/22024187 http://dx.doi.org/10.1186/1756-9966-30-101

Ejemplares similares

Dietary habits of lung cancer patients from the Lower Silesia region of Poland
por: Zabłocka-Słowińska, Katarzyna, et al.
Publicado: (2015)

Human leukocyte antigen (HLA)-G gene polymorphism in patients with non-small cell lung cancer
por: Kowal, Aneta, et al.
Publicado: (2015)

Total antioxidant status in lung cancer is associated with levels of endogenous antioxidants and disease stage rather than lifestyle factors – preliminary study
por: Zabłocka-Słowińska, Katarzyna, et al.
Publicado: (2016)

Nocturnal Hypoventilation in the Patients Submitted to Thoracic Surgery
por: Majchrzak, Maciej, et al.
Publicado: (2023)

The Relationships between cyclin D1 Expression and Prognosis of Non-small Cell Lung Cancer
por: ZHU, Jiping, et al.
Publicado: (2010)

Galectin Expression Profiling Identifies Galectin-1 and Galectin-9Δ5 as Prognostic Factors in Stage I/II Non-Small Cell Lung Cancer
por: Schulkens, Iris A., et al.
Publicado: (2014)

Cyclin D1 expression in KRAS mutant non-small cell lung cancer—old wine into new skins
por: Goh, Kah Yee, et al.
Publicado: (2020)

Cyclin D1 overexpression is an indicator of poor prognosis in resectable non-small cell lung cancer
por: Keum, J S, et al.
Publicado: (1999)

Inhibition of Cyclin D1 Expression and Induction of Apoptosis by Inostamycin in Small Cell Lung Carcinoma Cells
por: Imoto, Masaya, et al.
Publicado: (1998)

Prognostic Significance of Cyclin D1 Expression in Small Intestinal Adenocarcinoma
por: Jun, Sun-Young, et al.
Publicado: (2023)

Lung cancer in patients under the age of 40 years
por: Kozielski, Jerzy, et al.
Publicado: (2012)

Cyclin D1 expression in non-small-cell lung cancers: its association with altered p53 expression, cell proliferation and clinical outcome
por: Mishina, T, et al.
Publicado: (1999)

Prevalence and genotyping of Pneumocystis jirovecii in renal transplant recipients—preliminary report
por: Szydłowicz, Magdalena, et al.
Publicado: (2018)

Bronchial hyper-responsiveness, subepithelial fibrosis, and transforming growth factor-β(1) expression in patients with long-standing and recently diagnosed asthma
por: Tomkowicz, Aneta, et al.
Publicado: (2008)

Cyclin K interacts with β-catenin to induce Cyclin D1 expression and facilitates tumorigenesis and radioresistance in lung cancer
por: Yao, Guojun, et al.
Publicado: (2020)

Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer.
por: Betticher, D. C., et al.
Publicado: (1996)

Prognostic value of MET, cyclin D1 and MET gene copy number in non-small cell lung cancer
por: Sun, Wenze, et al.
Publicado: (2013)

miR-195 targets cyclin D3 and survivin to modulate the tumorigenesis of non-small cell lung cancer
por: Yu, Xiaojie, et al.
Publicado: (2018)

Deubiquitinase USP5 promotes non-small cell lung cancer cell proliferation by stabilizing cyclin D1
por: Zhang, Zhiwei, et al.
Publicado: (2021)

Hes3 Enhances the Malignant Phenotype of Lung Cancer through Upregulating Cyclin D1, Cyclin D3 and MMP7 Expression
por: Fang, Changqing, et al.
Publicado: (2019)

Cyclin A is associated with an unfavourable outcome in patients with non-small-cell lung carcinomas.
por: Volm, M., et al.
Publicado: (1997)

PIWIL2 promotes progression of non-small cell lung cancer by inducing CDK2 and Cyclin A expression
por: Qu, Xiaohan, et al.
Publicado: (2015)

Common inherited variants of PDCD1, CD274 and HAVCR2 genes differentially modulate the risk and prognosis of adenocarcinoma and squamous cell carcinoma
por: Moksud, Nafeesa, et al.
Publicado: (2023)

Diagnostic Power of Galectin-3 in Rheumatic Diseases
por: Gruszewska, Ewa, et al.
Publicado: (2020)

Xanthohumol targets the ERK1/2-Fra1 signaling axis to reduce cyclin D1 expression and inhibit non-small cell lung cancer
por: Gao, Feng, et al.
Publicado: (2020)

Galectin-3 and Cyclin D3 Immunohistochemistry and Tumor Dimensions Are Useful in Distinguishing Follicular Oncocytic Carcinomas from Oncocytic Adenomas of the Thyroid
por: Cacchi, C., et al.
Publicado: (2015)

Cyclin D1 expression in prostate carcinoma
por: Pereira, R.A., et al.
Publicado: (2014)

Role of galectins in lung cancer
por: Chang, Wei-An, et al.
Publicado: (2017)

Placental Expression Patterns of Galectin-1, Galectin-2, Galectin-3 and Galectin-13 in Cases of Intrauterine Growth Restriction (IUGR)
por: Hutter, Stefan, et al.
Publicado: (2016)

Streptozotocin-Induced Diabetes Causes Changes in Serotonin-Positive Neurons in the Small Intestine in Pig Model
por: Bulc, Michał, et al.
Publicado: (2022)

KIT Mutations Correlate with Higher Galectin Levels and Brain Metastasis in Breast and Non-Small Cell Lung Cancer
por: Funkhouser, Avery T., et al.
Publicado: (2022)

Characterization of D-Cyclin Proteins in Hematolymphoid Neoplasms: Lack of Specificity of Cyclins D2 and D3 Expression in Lymphoma Subtypes
por: Metcalf, Ryan A, et al.
Publicado: (2010)

Expression of cyclin D1 and cyclin E in human gastric carcinoma and its clinicopathologic significance.
por: Ahn, M. J., et al.
Publicado: (1998)

Polymorphisms of Antigen-Presenting Machinery Genes in Non-Small Cell Lung Cancer: Different Impact on Disease Risk and Clinical Parameters in Smokers and Never-Smokers
por: Wiśniewski, Andrzej, et al.
Publicado: (2021)

Preclinical Activity of Simvastatin Induces Cell Cycle Arrest in G1 via Blockade of Cyclin D-Cdk4 Expression in Non-Small Cell Lung Cancer (NSCLC)
por: Liang, Yu-Wei, et al.
Publicado: (2013)

Genetic Clonality as the Hallmark Driving Evolution of Non-Small Cell Lung Cancer
por: Nicoś, Marcin, et al.
Publicado: (2022)

Inhibition of galectin‐3 augments the antitumor efficacy of PD‐L1 blockade in non‐small‐cell lung cancer
por: Zhang, Hongxin, et al.
Publicado: (2021)

Cyclin C: The Story of a Non-Cycling Cyclin
por: Ježek, Jan, et al.
Publicado: (2019)

FGFR1–4 RNA-Based Gene Alteration and Expression Analysis in Squamous Non-Small Cell Lung Cancer
por: Moes-Sosnowska, Joanna, et al.
Publicado: (2022)

Cyclin D1 and D3 expression in melanocytic skin lesions
por: Alekseenko, Ana, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_q52g2f9294h96vishndip0ueql